MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 8 (2011), Issue 4 (April)

1. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci.
   Med Princ Pract, 20(3): 253-8. [Abstract] [Full-text]
2. Structural basis for ligand recognition and discrimination of a quorum quenching antibody.
   J Biol Chem. [Abstract] [Full-text]
3. Identification of Staphylococcus aureus Carrying the mecA Gene in Ready-to-Eat Food Products Sold in Brazil.
   Foodborne Pathog Dis, 8(4): 561-3. [Abstract] [Full-text]
4. Urine cultures from indwelling bladder catheters in nursing home patients: A point prevalence study in a Swedish county.
   Scand J Urol Nephrol. [Abstract] [Full-text]
5. Quantitative Proteomic View on Secreted, Cell Surface-Associated, and Cytoplasmic Proteins of the Methicillin-Resistant Human Pathogen Staphylococcus aureus under Iron-Limited Conditions.
   J Proteome Res, 10(4): 1657-1666. [Abstract] [Full-text]
6. Bacterial colonization patterns in neonates transferred from neonatal intensive care units.
   Int J Hyg Environ Health, 214(2): 167-71. [Abstract] [Full-text]
7. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci.
   Med Princ Pract, 20(3): 253-8. [Abstract] [Full-text]
8. Structural basis for ligand recognition and discrimination of a quorum quenching antibody.
   J Biol Chem. [Abstract] [Full-text]
9. Identification of Staphylococcus aureus Carrying the mecA Gene in Ready-to-Eat Food Products Sold in Brazil.
   Foodborne Pathog Dis, 8(4): 561-3. [Abstract] [Full-text]
10. Urine cultures from indwelling bladder catheters in nursing home patients: A point prevalence study in a Swedish county.
    Scand J Urol Nephrol. [Abstract] [Full-text]
11. Quantitative Proteomic View on Secreted, Cell Surface-Associated, and Cytoplasmic Proteins of the Methicillin-Resistant Human Pathogen Staphylococcus aureus under Iron-Limited Conditions.
    J Proteome Res, 10(4): 1657-1666. [Abstract] [Full-text]
12. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci.
    Med Princ Pract, 20(3): 253-8. [Abstract] [Full-text]
13. Identification of Staphylococcus aureus Carrying the mecA Gene in Ready-to-Eat Food Products Sold in Brazil.
    Foodborne Pathog Dis, 8(4): 561-3. [Abstract] [Full-text]
14. Urine cultures from indwelling bladder catheters in nursing home patients: A point prevalence study in a Swedish county.
    Scand J Urol Nephrol. [Abstract] [Full-text]
15. Quantitative Proteomic View on Secreted, Cell Surface-Associated, and Cytoplasmic Proteins of the Methicillin-Resistant Human Pathogen Staphylococcus aureus under Iron-Limited Conditions.
    J Proteome Res, 10(4): 1657-1666. [Abstract] [Full-text]
16. Vancomycin-resistance Transferability from VanA Enterococci to Staphylococcus aureus.
    Curr Microbiol, 62(5): 1363-7. [Abstract] [Full-text]
17. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus.
    Curr Microbiol, 62(5): 1363-7. [Abstract] [Full-text]
18. The impact of mixing surgical subspecialty patients on wound infection rates.
    Eur Arch Otorhinolaryngol. [Abstract] [Full-text]
19. Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
20. Community-acquired MRSA pyomyositis: case report and review of the literature.
    J Trop Med, 2011: 970848. [Abstract] [Full-text]
21. Assessment of the Influence of Test Characteristics on the Clinical and Cost Impacts of Methicillin-Resistant Staphylococcus aureus Screening Programs in US Hospitals.
    Infect Control Hosp Epidemiol, 32(3): 250-7. [Abstract] [Full-text]
22. Comparison of the Methicillin-Resistant Staphylococcus aureus Acquisition among Rehabilitation and Nursing Home Residents.
    Infect Control Hosp Epidemiol, 32(3): 244-9. [Abstract] [Full-text]
23. Impact of Chlorhexidine Bathing on Hospital-Acquired Infections among General Medical Patients.
    Infect Control Hosp Epidemiol, 32(3): 238-43. [Abstract] [Full-text]
24. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals.
    Infect Control Hosp Epidemiol, 32(4): 387-90. [Abstract] [Full-text]
25. Impact of Methicillin-Resistant Staphylococcus aureus Prevalence among S. aureus Isolates on Surgical Site Infection Risk after Coronary Artery Bypass Surgery.
    Infect Control Hosp Epidemiol, 32(4): 342-50. [Abstract] [Full-text]
26. Challenges of Applying the SHEA/HICPAC Metrics for Multidrug-Resistant Organisms to a Real-World Setting.
    Infect Control Hosp Epidemiol, 32(4): 323-32. [Abstract] [Full-text]
27. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the duke infection control outreach network.
    Infect Control Hosp Epidemiol, 32(4): 315-22. [Abstract] [Full-text]
28. Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Clin Infect Dis, 52(8): 997-1002. [Abstract] [Full-text]
29. Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets.
    Clin Infect Dis, 52(8): 975-81. [Abstract] [Full-text]
30. Vancomycin: We Can't Get There from Here.
    Clin Infect Dis, 52(8): 969-74. [Abstract] [Full-text]
31. Role of overcrowding in meticillin-resistant Staphylococcus aureus transmission: Bayesian network analysis for a single public hospital.
    J Hosp Infect. [Abstract] [Full-text]
32. Surgical site infections: incidence and trends at a community teaching hospital.
    Am J Surg. [Abstract] [Full-text]
33. Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus.
    Cell Immunol. [Abstract] [Full-text]
34. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites.
    Am J Infect Control, 39(3): 219-25. [Abstract] [Full-text]
35. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Am J Infect Control, 39(3): 188-93. [Abstract] [Full-text]
36. Label-free, electrochemical detection of methicillin-resistant staphylococcus aureus DNA with reduced graphene oxide-modified electrodes.
    Biosens Bioelectron. [Abstract] [Full-text]
37. Non-hospital-associated methicillin-resistant Staphylococcus aureus and MRSA chronic carrier patients in infection control.
    Am J Infect Control, 39(3): 250-3. [Abstract] [Full-text]
38. Preventing methicillin-resistant Staphylococcus aureus transmission in long-term care facilities: An executive summary of the APIC Elimination Guide.
    Am J Infect Control, 39(3): 235-8. [Abstract] [Full-text]
39. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J, 40(4): 555-64. [Abstract] [Full-text]
40. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
    Am J Infect Control, 39(3): 243-6. [Abstract] [Full-text]
41. The impact of mixing surgical subspecialty patients on wound infection rates.
    Eur Arch Otorhinolaryngol. [Abstract] [Full-text]
42. Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
43. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals.
    Infect Control Hosp Epidemiol, 32(4): 387-90. [Abstract] [Full-text]
44. Impact of Methicillin-Resistant Staphylococcus aureus Prevalence among S. aureus Isolates on Surgical Site Infection Risk after Coronary Artery Bypass Surgery.
    Infect Control Hosp Epidemiol, 32(4): 342-50. [Abstract] [Full-text]
45. Challenges of Applying the SHEA/HICPAC Metrics for Multidrug-Resistant Organisms to a Real-World Setting.
    Infect Control Hosp Epidemiol, 32(4): 323-32. [Abstract] [Full-text]
46. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the duke infection control outreach network.
    Infect Control Hosp Epidemiol, 32(4): 315-22. [Abstract] [Full-text]
47. Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Clin Infect Dis, 52(8): 997-1002. [Abstract] [Full-text]
48. Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets.
    Clin Infect Dis, 52(8): 975-81. [Abstract] [Full-text]
49. Vancomycin: We Can't Get There from Here.
    Clin Infect Dis, 52(8): 969-74. [Abstract] [Full-text]
50. Role of overcrowding in meticillin-resistant Staphylococcus aureus transmission: Bayesian network analysis for a single public hospital.
    J Hosp Infect. [Abstract] [Full-text]
51. Surgical site infections: incidence and trends at a community teaching hospital.
    Am J Surg. [Abstract] [Full-text]
52. Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus.
    Cell Immunol. [Abstract] [Full-text]
53. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites.
    Am J Infect Control, 39(3): 219-25. [Abstract] [Full-text]
54. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Am J Infect Control, 39(3): 188-93. [Abstract] [Full-text]
55. Non-hospital-associated methicillin-resistant Staphylococcus aureus and MRSA chronic carrier patients in infection control.
    Am J Infect Control, 39(3): 250-3. [Abstract] [Full-text]
56. Preventing methicillin-resistant Staphylococcus aureus transmission in long-term care facilities: An executive summary of the APIC Elimination Guide.
    Am J Infect Control, 39(3): 235-8. [Abstract] [Full-text]
57. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J, 40(4): 555-64. [Abstract] [Full-text]
58. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
    Am J Infect Control, 39(3): 243-6. [Abstract] [Full-text]
59. Molecular laboratory tests for the diagnosis of respiratory tract infection due to Staphylococcus aureus.
    Clin Infect Dis, 52: S361-6. [Abstract] [Full-text]
60. The impact of mixing surgical subspecialty patients on wound infection rates.
    Eur Arch Otorhinolaryngol. [Abstract] [Full-text]
61. Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
62. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals.
    Infect Control Hosp Epidemiol, 32(4): 387-90. [Abstract] [Full-text]
63. Impact of Methicillin-Resistant Staphylococcus aureus Prevalence among S. aureus Isolates on Surgical Site Infection Risk after Coronary Artery Bypass Surgery.
    Infect Control Hosp Epidemiol, 32(4): 342-50. [Abstract] [Full-text]
64. Challenges of Applying the SHEA/HICPAC Metrics for Multidrug-Resistant Organisms to a Real-World Setting.
    Infect Control Hosp Epidemiol, 32(4): 323-32. [Abstract] [Full-text]
65. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the duke infection control outreach network.
    Infect Control Hosp Epidemiol, 32(4): 315-22. [Abstract] [Full-text]
66. Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Clin Infect Dis, 52(8): 997-1002. [Abstract] [Full-text]
67. Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets.
    Clin Infect Dis, 52(8): 975-81. [Abstract] [Full-text]
68. Vancomycin: We Can't Get There from Here.
    Clin Infect Dis, 52(8): 969-74. [Abstract] [Full-text]
69. Role of overcrowding in meticillin-resistant Staphylococcus aureus transmission: Bayesian network analysis for a single public hospital.
    J Hosp Infect. [Abstract] [Full-text]
70. Surgical site infections: incidence and trends at a community teaching hospital.
    Am J Surg. [Abstract] [Full-text]
71. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites.
    Am J Infect Control, 39(3): 219-25. [Abstract] [Full-text]
72. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Am J Infect Control, 39(3): 188-93. [Abstract] [Full-text]
73. Non-hospital-associated methicillin-resistant Staphylococcus aureus and MRSA chronic carrier patients in infection control.
    Am J Infect Control, 39(3): 250-3. [Abstract] [Full-text]
74. Preventing methicillin-resistant Staphylococcus aureus transmission in long-term care facilities: An executive summary of the APIC Elimination Guide.
    Am J Infect Control, 39(3): 235-8. [Abstract] [Full-text]
75. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J, 40(4): 555-64. [Abstract] [Full-text]
76. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons.
    Neuroscience, 180: 53-63. [Abstract] [Full-text]
77. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
    Am J Infect Control, 39(3): 243-6. [Abstract] [Full-text]
78. Molecular laboratory tests for the diagnosis of respiratory tract infection due to Staphylococcus aureus.
    Clin Infect Dis, 52: S361-6. [Abstract] [Full-text]
79. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections.
    Clin Infect Dis, 52(8): 997-1002. [Abstract] [Full-text]
80. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
    Clin Infect Dis, 52(8): 975-81. [Abstract] [Full-text]
81. Vancomycin: we can't get there from here.
    Clin Infect Dis, 52(8): 969-74. [Abstract] [Full-text]
82. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons.
    Neuroscience, 180: 53-63. [Abstract] [Full-text]
83. MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery.
    J Bone Joint Surg Br, 93(4): 548-51. [Abstract] [Full-text]
84. In Vitro and In Vivo Profile of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
85. Infantile orbital cellulitis secondary to community-associated methicillin-resistant Staphylococcus aureus.
    J AAPOS. [Abstract] [Full-text]
86. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
    J Am Coll Surg, 212(4): 476-84. [Abstract] [Full-text]
87. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina.
    Infect Genet Evol. [Abstract] [Full-text]
88. MRSA: a case of pathogens, politics and penalties.
    Trends Microbiol, 19(4): 153-5. [Abstract] [Full-text]
89. Transmission of Methicillin-Resistant Staphylococcus aureus between Human and Hamster.
    J Clin Microbiol, 49(4): 1679-80. [Abstract] [Full-text]
90. Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype.
    J Clin Microbiol, 49(4): 1583-1587. [Abstract] [Full-text]
91. Comparison of the DiversiLab Repetitive Element PCR System with spa Typing and Pulsed-Field Gel Electrophoresis for Clonal Characterization of Methicillin-Resistant Staphylococcus aureus.
    J Clin Microbiol, 49(4): 1549-55. [Abstract] [Full-text]
92. Genotypic and Phenotypic Characterization of Methicillin-Susceptible Staphylococcus aureus Isolates Misidentified as Methicillin-Resistant Staphylococcus aureus by the BD GeneOhm MRSA Assay.
    J Clin Microbiol, 49(4): 1240-4. [Abstract] [Full-text]
93. Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates.
    J Clin Microbiol, 49(4): 1489-94. [Abstract] [Full-text]
94. MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery.
    J Bone Joint Surg Br, 93(4): 548-51. [Abstract] [Full-text]
95. In Vitro and In Vivo Profile of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
96. Infantile orbital cellulitis secondary to community-associated methicillin-resistant Staphylococcus aureus.
    J AAPOS. [Abstract] [Full-text]
97. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
    J Am Coll Surg, 212(4): 476-84. [Abstract] [Full-text]
98. MRSA: a case of pathogens, politics and penalties.
    Trends Microbiol, 19(4): 153-5. [Abstract] [Full-text]
99. Transmission of Methicillin-Resistant Staphylococcus aureus between Human and Hamster.
    J Clin Microbiol, 49(4): 1679-80. [Abstract] [Full-text]
100. Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype.
     J Clin Microbiol, 49(4): 1583-1587. [Abstract] [Full-text]
101. Comparison of the DiversiLab Repetitive Element PCR System with spa Typing and Pulsed-Field Gel Electrophoresis for Clonal Characterization of Methicillin-Resistant Staphylococcus aureus.
     J Clin Microbiol, 49(4): 1549-55. [Abstract] [Full-text]
102. Genotypic and Phenotypic Characterization of Methicillin-Susceptible Staphylococcus aureus Isolates Misidentified as Methicillin-Resistant Staphylococcus aureus by the BD GeneOhm MRSA Assay.
     J Clin Microbiol, 49(4): 1240-4. [Abstract] [Full-text]
103. Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates.
     J Clin Microbiol, 49(4): 1489-94. [Abstract] [Full-text]
104. MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery.
     J Bone Joint Surg Br, 93(4): 548-51. [Abstract] [Full-text]
105. In Vitro and In Vivo Profile of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
106. Infantile orbital cellulitis secondary to community-associated methicillin-resistant Staphylococcus aureus.
     J AAPOS. [Abstract] [Full-text]
107. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
     J Am Coll Surg, 212(4): 476-84. [Abstract] [Full-text]
108. MRSA: a case of pathogens, politics and penalties.
     Trends Microbiol, 19(4): 153-5. [Abstract] [Full-text]
109. Transmission of Methicillin-Resistant Staphylococcus aureus between Human and Hamster.
     J Clin Microbiol, 49(4): 1679-80. [Abstract] [Full-text]
110. Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype.
     J Clin Microbiol, 49(4): 1583-1587. [Abstract] [Full-text]
111. Comparison of the DiversiLab Repetitive Element PCR System with spa Typing and Pulsed-Field Gel Electrophoresis for Clonal Characterization of Methicillin-Resistant Staphylococcus aureus.
     J Clin Microbiol, 49(4): 1549-55. [Abstract] [Full-text]
112. Genotypic and Phenotypic Characterization of Methicillin-Susceptible Staphylococcus aureus Isolates Misidentified as Methicillin-Resistant Staphylococcus aureus by the BD GeneOhm MRSA Assay.
     J Clin Microbiol, 49(4): 1240-4. [Abstract] [Full-text]
113. Assessing the probability of acquisition of meticillin-resistant Staphylococcus aureus (MRSA) in a dog using a nested stochastic simulation model and logistic regression sensitivity analysis.
     Prev Vet Med, 99(2): 211-24. [Abstract] [Full-text]
114. Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates.
     J Clin Microbiol, 49(4): 1489-94. [Abstract] [Full-text]
115. Assessing the probability of acquisition of meticillin-resistant Staphylococcus aureus (MRSA) in a dog using a nested stochastic simulation model and logistic regression sensitivity analysis.
     Prev Vet Med, 99(2): 211-24. [Abstract] [Full-text]
116. Antibacterial activities of macrolactin a and 7-O-succinyl macrolactin a from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
     Arch Pharm Res, 34(1): 147-52. [Abstract] [Full-text]
117. Seasonality of MRSA infections.
     PLoS One, 6(3): e17925. [Abstract] [Full-text]
118. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
     Phytomedicine. [Abstract] [Full-text]
119. Antibacterial activities of macrolactin a and 7-O-succinyl macrolactin a from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
     Arch Pharm Res, 34(1): 147-52. [Abstract] [Full-text]
120. Seasonality of MRSA infections.
     PLoS One, 6(3): e17925. [Abstract] [Full-text]
121. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
     Phytomedicine. [Abstract] [Full-text]
122. Antibacterial activities of macrolactin a and 7-O-succinyl macrolactin a from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
     Arch Pharm Res, 34(1): 147-52. [Abstract] [Full-text]
123. Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus.
     Clin Infect Dis, 52(9): 1156-63. [Abstract] [Full-text]
124. The challenges of antimicrobial resistance in Brazil.
     Clin Infect Dis, 52(9): 1138-43. [Abstract] [Full-text]
125. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
     Phytomedicine. [Abstract] [Full-text]
126. Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
     Clin Infect Dis, 52(9): 1156-63. [Abstract] [Full-text]
127. The challenges of antimicrobial resistance in Brazil.
     Clin Infect Dis, 52(9): 1138-43. [Abstract] [Full-text]
128. Mandatory public reporting of hospital-acquired infection rates: a report from california.
     Health Aff (Millwood), 30(4): 723-9. [Abstract] [Full-text]
129. Rapid Differentiation of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus by Flow Cytometry After Brief Antibiotic Exposure.
     J Clin Microbiol. [Abstract] [Full-text]
130. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates.
     Int Wound J. [Abstract] [Full-text]
131. Diagnosis and treatment of pediatric chronic osteomyelitis in developing countries: prospective study of 96 patients treated in Kenya.
     Musculoskelet Surg, 95(1): 13-8. [Abstract] [Full-text]
132. Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: A 12-year experience.
     Ann Med. [Abstract] [Full-text]
133. Mandatory public reporting of hospital-acquired infection rates: a report from california.
     Health Aff (Millwood), 30(4): 723-9. [Abstract] [Full-text]
134. Rapid Differentiation of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus by Flow Cytometry After Brief Antibiotic Exposure.
     J Clin Microbiol. [Abstract] [Full-text]
135. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates.
     Int Wound J. [Abstract] [Full-text]
136. Septic elbow in the setting of neuropathic joint as the initial presentation of a cervical syrinx.
     Orthopedics, 34(4). [Abstract] [Full-text]
137. Diagnosis and treatment of pediatric chronic osteomyelitis in developing countries: prospective study of 96 patients treated in Kenya.
     Musculoskelet Surg, 95(1): 13-8. [Abstract] [Full-text]
138. Mandatory public reporting of hospital-acquired infection rates: a report from california.
     Health Aff (Millwood), 30(4): 723-9. [Abstract] [Full-text]
139. Rapid Differentiation of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus by Flow Cytometry After Brief Antibiotic Exposure.
     J Clin Microbiol. [Abstract] [Full-text]
140. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates.
     Int Wound J. [Abstract] [Full-text]
141. Septic elbow in the setting of neuropathic joint as the initial presentation of a cervical syrinx.
     Orthopedics, 34(4). [Abstract] [Full-text]
142. Diagnosis and treatment of pediatric chronic osteomyelitis in developing countries: prospective study of 96 patients treated in Kenya.
     Musculoskelet Surg, 95(1): 13-8. [Abstract] [Full-text]
143. Septic elbow in the setting of neuropathic joint as the initial presentation of a cervical syrinx.
     Orthopedics, 34(4). [Abstract] [Full-text]
144. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.
     J Hosp Infect. [Abstract] [Full-text]
145. The performance of the BD geneOhm MRSA™ assay for MRSA isolated from clinical patients in Japan, including the effects of specimen contamination and ways to improve it.
     J Infect Chemother, 17(2): 214-8. [Abstract] [Full-text]
146. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
     J Infect Chemother, 17(2): 297-300. [Abstract] [Full-text]
147. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.
     J Hosp Infect. [Abstract] [Full-text]
148. The performance of the BD geneOhm MRSA™ assay for MRSA isolated from clinical patients in Japan, including the effects of specimen contamination and ways to improve it.
     J Infect Chemother, 17(2): 214-8. [Abstract] [Full-text]
149. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
     J Infect Chemother, 17(2): 297-300. [Abstract] [Full-text]
150. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.
     J Hosp Infect. [Abstract] [Full-text]
151. The performance of the BD geneOhm MRSA™ assay for MRSA isolated from clinical patients in Japan, including the effects of specimen contamination and ways to improve it.
     J Infect Chemother, 17(2): 214-8. [Abstract] [Full-text]
152. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
     J Infect Chemother, 17(2): 297-300. [Abstract] [Full-text]
153. MRSA SCCmec epidemiology in Israel: development and implementation of an MRSA SCCmec typing strategy.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
154. mec-associated dru typing in the epidemiological analysis of ST239 MRSA in Malaysia.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
155. An Antimicrobial Compound Isolated from Cinnamomum Iners Leaves with Activity against Methicillin-Resistant Staphylococcus Aureus.
     Molecules, 16(4): 3037-47. [Abstract] [Full-text]
156. Digital Isothermal Quantification of Nucleic Acids via Simultaneous Chemical Initiation of Recombinase Polymerase Amplification Reactions on SlipChip.
     Anal Chem. [Abstract] [Full-text]
157. Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus.
     FEMS Microbiol Lett, 318(2): 168-76. [Abstract] [Full-text]
158. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: A randomized controlled trial.
     J Hosp Med, 6(4): 109-14. [Abstract] [Full-text]
159. MRSA SCCmec epidemiology in Israel: development and implementation of an MRSA SCCmec typing strategy.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
160. mec-associated dru typing in the epidemiological analysis of ST239 MRSA in Malaysia.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
161. An Antimicrobial Compound Isolated from Cinnamomum Iners Leaves with Activity against Methicillin-Resistant Staphylococcus Aureus.
     Molecules, 16(4): 3037-47. [Abstract] [Full-text]
162. Innovative solutions: beds, baths, and bottoms: a quality improvement initiative to standardize use of beds, bathing techniques, and skin care in a general critical-care unit.
     Dimens Crit Care Nurs, 30(3): 169-76. [Abstract] [Full-text]
163. Methicillin-Resistant Staphylococcus aureus Hand Infections in a Suburban Community Hospital.
     Ann Plast Surg, 66(5): 486-7. [Abstract] [Full-text]
164. Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus.
     FEMS Microbiol Lett, 318(2): 168-76. [Abstract] [Full-text]
165. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: A randomized controlled trial.
     J Hosp Med, 6(4): 109-14. [Abstract] [Full-text]
166. Innovative solutions: beds, baths, and bottoms: a quality improvement initiative to standardize use of beds, bathing techniques, and skin care in a general critical-care unit.
     Dimens Crit Care Nurs, 30(3): 169-76. [Abstract] [Full-text]
167. Methicillin-resistant Staphylococcus aureus hand infections in a suburban community hospital.
     Ann Plast Surg, 66(5): 486-7. [Abstract] [Full-text]
168. Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus.
     FEMS Microbiol Lett, 318(2): 168-76. [Abstract] [Full-text]
169. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
     J Antimicrob Chemother, 66: iii69-iii80. [Abstract] [Full-text]
170. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
     J Antimicrob Chemother, 66: iii45-iii51. [Abstract] [Full-text]
171. Changing needs of community-acquired pneumonia.
     J Antimicrob Chemother, 66: iii3-iii9. [Abstract] [Full-text]
172. Ceftaroline fosamil: a new broad-spectrum cephalosporin.
     J Antimicrob Chemother, 66: iii11-iii18. [Abstract] [Full-text]
173. Evaluation of risk factors for hospital mortality and current treatment for poststernotomy mediastinitis.
     Gen Thorac Cardiovasc Surg, 59(4): 261-7. [Abstract] [Full-text]
174. Detection of methicillin-resistant Staphylococcus aureus with high-level resistance to mupirocin.
     J Infect Chemother. [Abstract] [Full-text]
175. A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic.
     PLoS One, 6(3): e18031. [Abstract] [Full-text]
176. Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus.
     PLoS One, 6(3): e14783. [Abstract] [Full-text]
177. Antibiotics, Acne, and Staphylococcus aureus Colonization.
     Arch Dermatol. [Abstract] [Full-text]
178. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.
     Int J Antimicrob Agents. [Abstract] [Full-text]
179. Synthesis and in vitro antibacterial activity of 7-(3-Alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
     Eur J Med Chem. [Abstract] [Full-text]
180. Bacterial contamination of hands and the environment in a microbiology laboratory.
     J Hosp Infect. [Abstract] [Full-text]
181. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany.
     J Hosp Infect. [Abstract] [Full-text]
182. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients.
     J Hosp Infect. [Abstract] [Full-text]
183. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens.
     Microb Biotechnol. [Abstract] [Full-text]
184. Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units.
     Acta Anaesthesiol Scand. [Abstract] [Full-text]
185. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina.
     Infect Genet Evol. [Abstract] [Full-text]
186. Methicillin resistant Staphylococcus aureus adhesion to human umbilical vein endothelial cells demonstrates wall shear stress dependent behaviour.
     Biomed Eng Online, 10: 20. [Abstract] [Full-text]
187. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
     J Antimicrob Chemother, 66: iii69-80. [Abstract] [Full-text]
188. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
     J Antimicrob Chemother, 66: iii45-51. [Abstract] [Full-text]
189. Changing needs of community-acquired pneumonia.
     J Antimicrob Chemother, 66: iii3-9. [Abstract] [Full-text]
190. Ceftaroline fosamil: a new broad-spectrum cephalosporin.
     J Antimicrob Chemother, 66: iii11-8. [Abstract] [Full-text]
191. Evaluation of risk factors for hospital mortality and current treatment for poststernotomy mediastinitis.
     Gen Thorac Cardiovasc Surg, 59(4): 261-7. [Abstract] [Full-text]
192. Detection of methicillin-resistant Staphylococcus aureus with high-level resistance to mupirocin.
     J Infect Chemother. [Abstract] [Full-text]
193. A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic.
     PLoS One, 6(3): e18031. [Abstract] [Full-text]
194. Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus.
     PLoS One, 6(3): e14783. [Abstract] [Full-text]
195. Antibiotics, Acne, and Staphylococcus aureus Colonization.
     Arch Dermatol. [Abstract] [Full-text]
196. Bacterial contamination of hands and the environment in a microbiology laboratory.
     J Hosp Infect. [Abstract] [Full-text]
197. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany.
     J Hosp Infect. [Abstract] [Full-text]
198. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients.
     J Hosp Infect. [Abstract] [Full-text]
199. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens.
     Microb Biotechnol. [Abstract] [Full-text]
200. Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units.
     Acta Anaesthesiol Scand. [Abstract] [Full-text]
201. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.
     J Antimicrob Chemother, 66(5): 997-1000. [Abstract] [Full-text]
202. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study.
     J Antimicrob Chemother, 66(5): 1061-1069. [Abstract] [Full-text]
203. The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother, 66(5): 985-96. [Abstract] [Full-text]
204. Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy.
     J Antimicrob Chemother, 66(5): 1168-73. [Abstract] [Full-text]
205. Evaluation of risk factors for hospital mortality and current treatment for poststernotomy mediastinitis.
     Gen Thorac Cardiovasc Surg, 59(4): 261-7. [Abstract] [Full-text]
206. Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
     Bioorg Med Chem, 19(8): 2696-706. [Abstract] [Full-text]
207. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.
     J Antimicrob Chemother, 66(5): 997-1000. [Abstract] [Full-text]
208. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study.
     J Antimicrob Chemother, 66(5): 1061-9. [Abstract] [Full-text]
209. The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother, 66(5): 985-96. [Abstract] [Full-text]
210. Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy.
     J Antimicrob Chemother, 66(5): 1168-73. [Abstract] [Full-text]
211. The Emergence of Staphylococcus aureus ST398.
     Vector Borne Zoonotic Dis, 11(4): 327-39. [Abstract] [Full-text]
212. Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?
     Eur J Clin Microbiol Infect Dis, 30(5): 677-83. [Abstract] [Full-text]
213. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient-a review of the literature.
     Eur J Clin Microbiol Infect Dis, 30(5): 603-10. [Abstract] [Full-text]
214. The Emergence of Staphylococcus aureus ST398.
     Vector Borne Zoonotic Dis, 11(4): 327-39. [Abstract] [Full-text]
215. Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?
     Eur J Clin Microbiol Infect Dis, 30(5): 677-83. [Abstract] [Full-text]
216. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
     Eur J Clin Microbiol Infect Dis, 30(5): 603-10. [Abstract] [Full-text]
217. Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.
     Biotechnol J. [Abstract] [Full-text]
218. Detection of vancomycin-intermediately susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and agar screening methods.
     J Clin Microbiol. [Abstract] [Full-text]
219. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.
     N Engl J Med, 364(15): 1419-30. [Abstract] [Full-text]
220. Intervention to reduce transmission of resistant bacteria in intensive care.
     N Engl J Med, 364(15): 1407-18. [Abstract] [Full-text]
221. Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases.
     J Med Chem. [Abstract] [Full-text]
222. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
     J Basic Microbiol, 51(2): 191-5. [Abstract] [Full-text]
223. Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.
     Biotechnol J. [Abstract] [Full-text]
224. Detection of vancomycin-intermediately susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and agar screening methods.
     J Clin Microbiol. [Abstract] [Full-text]
225. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.
     N Engl J Med, 364(15): 1419-30. [Abstract] [Full-text]
226. Intervention to reduce transmission of resistant bacteria in intensive care.
     N Engl J Med, 364(15): 1407-18. [Abstract] [Full-text]
227. Molecular Distinctions Exist Between Community-associated Methicillin-resistant Staphylococcus aureus Colonization and Disease-associated Isolates in Children.
     Pediatr Infect Dis J, 30(5): 418-21. [Abstract] [Full-text]
228. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21(st) century.
     J Dtsch Dermatol Ges, 9(5): 360-6. [Abstract] [Full-text]
229. Secular trends in antibiotic use among neonates: 2001-2008.
     Pediatr Infect Dis J, 30(5): 365-70. [Abstract] [Full-text]
230. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
     J Basic Microbiol, 51(2): 191-5. [Abstract] [Full-text]
231. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.
     N Engl J Med, 364(15): 1419-30. [Abstract] [Full-text]
232. Intervention to reduce transmission of resistant bacteria in intensive care.
     N Engl J Med, 364(15): 1407-18. [Abstract] [Full-text]
233. Molecular distinctions exist between community-associated methicillin-resistant Staphylococcus aureus colonization and disease-associated isolates in children.
     Pediatr Infect Dis J, 30(5): 418-21. [Abstract] [Full-text]
234. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21st century.
     J Dtsch Dermatol Ges, 9(5): 360-6. [Abstract] [Full-text]
235. Secular trends in antibiotic use among neonates: 2001-2008.
     Pediatr Infect Dis J, 30(5): 365-70. [Abstract] [Full-text]
236. Identification of Single Nucleotide Polymorphisms Associated with Hyperproduction of Alpha-Toxin in Staphylococcus aureus.
     PLoS One, 6(4): e18428. [Abstract] [Full-text]
237. A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus.
     PLoS One, 6(4): e17936. [Abstract] [Full-text]
238. Complications in pediatric deep neck space abscesses.
     Otolaryngol Head Neck Surg, 144(4): 592-5. [Abstract] [Full-text]
239. Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
     Bioorg Med Chem. [Abstract] [Full-text]
240. Predictors of nosocomial bloodstream infections in older adults.
     J Am Geriatr Soc, 59(4): 622-7. [Abstract] [Full-text]
241. Identification of Single Nucleotide Polymorphisms Associated with Hyperproduction of Alpha-Toxin in Staphylococcus aureus.
     PLoS One, 6(4): e18428. [Abstract] [Full-text]
242. A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus.
     PLoS One, 6(4): e17936. [Abstract] [Full-text]
243. Complications in pediatric deep neck space abscesses.
     Otolaryngol Head Neck Surg, 144(4): 592-5. [Abstract] [Full-text]
244. Predictors of nosocomial bloodstream infections in older adults.
     J Am Geriatr Soc, 59(4): 622-7. [Abstract] [Full-text]
245. DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
246. Ophthalmic Methicillin-resistant Staphylococcus aureus Infections: Sensitivity and Resistance Profiles of 234 Isolates.
     J Community Health. [Abstract] [Full-text]
247. Performance evaluation of a modified chromogenic medium, ChromID MRSA New, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
248. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis.
     J Hosp Infect. [Abstract] [Full-text]
249. Chemical constituents from endophytic fungus Fusarium oxysporum.
     Fitoterapia. [Abstract] [Full-text]
250. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
     Int J Antimicrob Agents. [Abstract] [Full-text]
251. Evaluation of the Xpert™ MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens.
     Diagn Microbiol Infect Dis. [Abstract] [Full-text]
252. Evidence for a purifying selection acting on the beta-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus.
     BMC Microbiol, 11(1): 76. [Abstract] [Full-text]
253. Surgical experience of 13 infected infrarenal aortoiliac aneurysms: Preoperative control of septic condition determines early outcome.
     Surgery, 149(5): 699-704. [Abstract] [Full-text]
254. Exploration of the Activity of 7-Pyrrolidino-8-methoxyisothiazoloquinolones against Methicillin-Resistant Staphylococcus aureus (MRSA).
     J Med Chem. [Abstract] [Full-text]
255. The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients.
     AIDS, 25(7): 1001-3. [Abstract] [Full-text]
256. DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
257. Ophthalmic Methicillin-resistant Staphylococcus aureus Infections: Sensitivity and Resistance Profiles of 234 Isolates.
     J Community Health. [Abstract] [Full-text]
258. Performance evaluation of a modified chromogenic medium, ChromID MRSA New, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
259. Total synthesis and biological evaluation of marinopyrrole A and analogues.
     Tetrahedron Lett, 52(17): 2041-2043. [Abstract] [Full-text]
260. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis.
     J Hosp Infect. [Abstract] [Full-text]
261. Evaluation of the Xpert™ MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens.
     Diagn Microbiol Infect Dis. [Abstract] [Full-text]
262. Evidence for a purifying selection acting on the beta-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus.
     BMC Microbiol, 11(1): 76. [Abstract] [Full-text]
263. Carriage of methicillin-resistant Staphylococcus aureus by veterinarians in Australia.
     Aust Vet J, 89(5): 152-159. [Abstract] [Full-text]
264. Surgical experience of 13 infected infrarenal aortoiliac aneurysms: Preoperative control of septic condition determines early outcome.
     Surgery, 149(5): 699-704. [Abstract] [Full-text]
265. The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients.
     AIDS, 25(7): 1001-3. [Abstract] [Full-text]
266. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study.
     J Hosp Infect, 78(1): 36-40. [Abstract] [Full-text]
267. Carriage of methicillin-resistant Staphylococcus aureus by veterinarians in Australia.
     Aust Vet J, 89(5): 152-9. [Abstract] [Full-text]
268. Surgical experience of 13 infected infrarenal aortoiliac aneurysms: preoperative control of septic condition determines early outcome.
     Surgery, 149(5): 699-704. [Abstract] [Full-text]
269. The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients.
     AIDS, 25(7): 1001-3. [Abstract] [Full-text]
270. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study.
     J Hosp Infect, 78(1): 36-40. [Abstract] [Full-text]
271. Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering SarA and rot global regulators of Staphylococcus aureus.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
272. Pharmacological Properties of the Marine Natural Product Marinopyrrole A Against Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
273. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
274. Preferential Emergence of Reduced Vancomycin Susceptibility in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) during Continuous Infusion Vancomycin Therapy (CIV) in an In Vitro Dynamic Model.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
275. In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus In a Mouse Thigh Infection Model.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
276. Impact of screening and identifying methicillin-resistant Staphylococcus aureus carriers on hand hygiene compliance in 4 intensive care units.
     Am J Infect Control. [Abstract] [Full-text]
277. Assessing the efficacy of different microfibre cloths at removing surface micro-organisms associated with healthcare-associated infections.
     J Hosp Infect. [Abstract] [Full-text]
278. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
     Acc Chem Res, 44(4): 261-8. [Abstract] [Full-text]
279. Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: Molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus.
     Pediatr Int, 53(2): 211-7. [Abstract] [Full-text]
280. Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering SarA and rot global regulators of Staphylococcus aureus.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
281. Pharmacological Properties of the Marine Natural Product Marinopyrrole A Against Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
282. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
283. Preferential Emergence of Reduced Vancomycin Susceptibility in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) during Continuous Infusion Vancomycin Therapy (CIV) in an In Vitro Dynamic Model.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
284. In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus In a Mouse Thigh Infection Model.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
285. Impact of screening and identifying methicillin-resistant Staphylococcus aureus carriers on hand hygiene compliance in 4 intensive care units.
     Am J Infect Control. [Abstract] [Full-text]
286. Assessing the efficacy of different microfibre cloths at removing surface micro-organisms associated with healthcare-associated infections.
     J Hosp Infect. [Abstract] [Full-text]
287. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
     Acc Chem Res, 44(4): 261-8. [Abstract] [Full-text]
288. Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: Molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus.
     Pediatr Int, 53(2): 211-7. [Abstract] [Full-text]
289. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
     Acc Chem Res, 44(4): 261-8. [Abstract] [Full-text]
290. Selective Decontamination of the Digestive Tract (SDD): Is the Game Worth the Candle?
     Semin Respir Crit Care Med, 32(2): 236-42. [Abstract] [Full-text]
291. Therapies against Virulence Products of Staphylococcus aureus and Pseudomonas aeruginosa.
     Semin Respir Crit Care Med, 32(2): 228-35. [Abstract] [Full-text]
292. Biodegradable nanostructures with selective lysis of microbial membranes.
     Nat Chem, 3(5): 409-14. [Abstract] [Full-text]
293. Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?
     Expert Rev Anti Infect Ther, 9(4): 389-92. [Abstract] [Full-text]
294. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.
     Drugs, 71(6): 757-70. [Abstract] [Full-text]
295. Role of the Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis.
     Infect Immun, 79(5): 1927-35. [Abstract] [Full-text]
296. Participation of CD11c+ Leukocytes in Methicillin-Resistant Staphylococcus aureus Clearance from the Lung.
     Infect Immun, 79(5): 1898-904. [Abstract] [Full-text]
297. Selective Decontamination of the Digestive Tract (SDD): Is the Game Worth the Candle?
     Semin Respir Crit Care Med, 32(2): 236-42. [Abstract] [Full-text]
298. Therapies against Virulence Products of Staphylococcus aureus and Pseudomonas aeruginosa.
     Semin Respir Crit Care Med, 32(2): 228-35. [Abstract] [Full-text]
299. Biodegradable nanostructures with selective lysis of microbial membranes.
     Nat Chem, 3(5): 409-14. [Abstract] [Full-text]
300. Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?
     Expert Rev Anti Infect Ther, 9(4): 389-92. [Abstract] [Full-text]
301. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.
     Drugs, 71(6): 757-70. [Abstract] [Full-text]
302. Role of the Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis.
     Infect Immun, 79(5): 1927-35. [Abstract] [Full-text]
303. Participation of CD11c+ Leukocytes in Methicillin-Resistant Staphylococcus aureus Clearance from the Lung.
     Infect Immun, 79(5): 1898-904. [Abstract] [Full-text]
304. Selective decontamination of the digestive tract (SDD): is the game worth the candle?
     Semin Respir Crit Care Med, 32(2): 236-42. [Abstract] [Full-text]
305. Therapies against virulence products of Staphylococcus aureus and Pseudomonas aeruginosa.
     Semin Respir Crit Care Med, 32(2): 228-35. [Abstract] [Full-text]
306. Biodegradable nanostructures with selective lysis of microbial membranes.
     Nat Chem, 3(5): 409-14. [Abstract] [Full-text]
307. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.
     Drugs, 71(6): 757-70. [Abstract] [Full-text]
308. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.
     Infect Immun, 79(5): 1927-35. [Abstract] [Full-text]
309. Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung.
     Infect Immun, 79(5): 1898-904. [Abstract] [Full-text]
310. Performance of the BD GeneOhmTM MRSA Achromopeptidase (ACP) Extraction for Real-time PCR Detection of Methicillin-resistant Staphylococcus aureus (MRSA) in Nasal Specimens.
     J Clin Microbiol. [Abstract] [Full-text]
311. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong.
     J Hosp Infect. [Abstract] [Full-text]
312. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
     J Hosp Infect. [Abstract] [Full-text]
313. Characterization of Methicillin-resistant Staphylococcus aureus isolated from public surfaces on a University Campus, Student Homes and Local Community.
     J Appl Microbiol. [Abstract] [Full-text]
314. The antimicrobial activity of inert oligonuclear polypyridylruthenium(ii) complexes against pathogenic bacteria, including MRSA.
     Dalton Trans, 40(18): 5032-8. [Abstract] [Full-text]
315. Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges.
     J Appl Microbiol. [Abstract] [Full-text]
316. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores.
     Infection, 39(2): 141-7. [Abstract] [Full-text]
317. Performance of the BD GeneOhmTM MRSA Achromopeptidase (ACP) Extraction for Real-time PCR Detection of Methicillin-resistant Staphylococcus aureus (MRSA) in Nasal Specimens.
     J Clin Microbiol. [Abstract] [Full-text]
318. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong.
     J Hosp Infect. [Abstract] [Full-text]
319. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
     J Hosp Infect. [Abstract] [Full-text]
320. Characterization of Methicillin-resistant Staphylococcus aureus isolated from public surfaces on a University Campus, Student Homes and Local Community.
     J Appl Microbiol. [Abstract] [Full-text]
321. The antimicrobial activity of inert oligonuclear polypyridylruthenium(ii) complexes against pathogenic bacteria, including MRSA.
     Dalton Trans, 40(18): 5032-8. [Abstract] [Full-text]
322. Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges.
     J Appl Microbiol. [Abstract] [Full-text]
323. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores.
     Infection, 39(2): 141-7. [Abstract] [Full-text]
324. Virulence and Resistance Determinants of German Staphylococcus aureus ST398 Isolates from Nonhuman Sources.
     Appl Environ Microbiol, 77(9): 3052-60. [Abstract] [Full-text]
325. Detection and characterization of an ST97-SCCmec-V community-associated meticillin-resistant Staphylococcus aureus clone in a neonatal intensive care unit and special care baby unit.
     J Med Microbiol, 60: 600-4. [Abstract] [Full-text]
326. Testing Spatiotemporal Hypothesis of Bacterial Evolution Using Methicillin-Resistant Staphylococcus aureus ST239 Genome-wide Data within a Bayesian Framework.
     Mol Biol Evol, 28(5): 1593-603. [Abstract] [Full-text]
327. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA.
     Dalton Trans, 40(18): 5032-8. [Abstract] [Full-text]
328. Virulence and resistance determinants of German Staphylococcus aureus ST398 isolates from nonhuman sources.
     Appl Environ Microbiol, 77(9): 3052-60. [Abstract] [Full-text]
329. Detection and characterization of an ST97-SCCmec-V community-associated meticillin-resistant Staphylococcus aureus clone in a neonatal intensive care unit and special care baby unit.
     J Med Microbiol, 60: 600-4. [Abstract] [Full-text]
330. A novel sequence-based coa genotyping method to discriminate nosocomial methicillin-resistant Staphylococcus aureus isolates.
     Ir J Med Sci, 180(2): 463-8. [Abstract] [Full-text]
331. Testing spatiotemporal hypothesis of bacterial evolution using methicillin-resistant Staphylococcus aureus ST239 genome-wide data within a bayesian framework.
     Mol Biol Evol, 28(5): 1593-603. [Abstract] [Full-text]
332. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
     J Hosp Infect. [Abstract] [Full-text]
333. Molecular Characterization of an Early Invasive Staphylococcus epidermidis Prosthetic Joint Infection.
     Microb Drug Resist. [Abstract] [Full-text]
334. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
     J Hosp Infect. [Abstract] [Full-text]
335. Molecular Characterization of an Early Invasive Staphylococcus epidermidis Prosthetic Joint Infection.
     Microb Drug Resist. [Abstract] [Full-text]
336. Systematic Review of Measurement and Adjustment for Colonization Pressure in Studies of Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and Clostridium difficile Acquisition.
     Infect Control Hosp Epidemiol, 32(5): 481-9. [Abstract] [Full-text]
337. Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
     Bioorg Med Chem. [Abstract] [Full-text]
338. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
     Int J Antimicrob Agents. [Abstract] [Full-text]
339. The role of mecA and blaZ regulatory elements in mecA expression by regional clones of methicillin-resistant Staphylococcus pseudintermedius.
     Vet Microbiol. [Abstract] [Full-text]
340. Chinks in the armor: The role of the nonclinical environment in the transmission of Staphylococcus bacteria.
     Am J Infect Control. [Abstract] [Full-text]
341. Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection.
     Diagn Microbiol Infect Dis, 70(1): 101-11. [Abstract] [Full-text]
342. Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones.
     Diagn Microbiol Infect Dis, 70(1): 22-30. [Abstract] [Full-text]
343. Chemical constituents from endophytic fungus Fusarium oxysporum.
     Fitoterapia. [Abstract] [Full-text]
344. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
     Int J Antimicrob Agents, 37(6): 562-6. [Abstract] [Full-text]
345. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.
     Int J Antimicrob Agents, 37(6): 550-3. [Abstract] [Full-text]
346. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.
     Diagn Microbiol Infect Dis, 70(1): 112-8. [Abstract] [Full-text]
347. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?
     Diagn Microbiol Infect Dis, 70(1): 124-30. [Abstract] [Full-text]
348. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
     Diagn Microbiol Infect Dis, 70(1): 37-44. [Abstract] [Full-text]
349. A Randomized Controlled Trial of Incision and Drainage Versus Ultrasonographically Guided Needle Aspiration for Skin Abscesses and the Effect of Methicillin-Resistant Staphylococcus aureus.
     Ann Emerg Med, 57(5): 483-491.e1. [Abstract] [Full-text]
350. Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department.
     Ann Emerg Med, 57(5): 492-9. [Abstract] [Full-text]
351. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.
     Infect Control Hosp Epidemiol, 32(5): 481-9. [Abstract] [Full-text]
352. Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection.
     Diagn Microbiol Infect Dis, 70(1): 101-11. [Abstract] [Full-text]
353. Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones.
     Diagn Microbiol Infect Dis, 70(1): 22-30. [Abstract] [Full-text]
354. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
     Int J Antimicrob Agents, 37(6): 562-6. [Abstract] [Full-text]
355. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.
     Int J Antimicrob Agents, 37(6): 550-3. [Abstract] [Full-text]
356. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
     Int J Antimicrob Agents, 37(6): 576-9. [Abstract] [Full-text]
357. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.
     Diagn Microbiol Infect Dis, 70(1): 112-8. [Abstract] [Full-text]
358. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?
     Diagn Microbiol Infect Dis, 70(1): 124-30. [Abstract] [Full-text]
359. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
     Diagn Microbiol Infect Dis, 70(1): 37-44. [Abstract] [Full-text]
360. A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus.
     Ann Emerg Med, 57(5): 483-91.e1. [Abstract] [Full-text]
361. Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department.
     Ann Emerg Med, 57(5): 492-9. [Abstract] [Full-text]
362. Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic Fibrosis.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
363. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
     Microb Biotechnol, 4(3): 375-82. [Abstract] [Full-text]
364. Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection.
     Br J Dermatol, 164(5): 987-995. [Abstract] [Full-text]
365. Community-Associated Methicillin-Resistant Staphylococcus aureus Survival on Artificial Turf Substrates.
     Med Sci Sports Exerc, 43(5): 779-84. [Abstract] [Full-text]
366. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
     Microb Biotechnol, 4(3): 375-82. [Abstract] [Full-text]
367. Characterization of a mixed MRSA/MRSE biofilm in an explanted total ankle arthroplasty.
     FEMS Immunol Med Microbiol, 62(1): 66-74. [Abstract] [Full-text]
368. Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection.
     Br J Dermatol, 164(5): 987-95. [Abstract] [Full-text]
369. Community-associated methicillin-resistant Staphylococcus aureus survival on artificial turf substrates.
     Med Sci Sports Exerc, 43(5): 779-84. [Abstract] [Full-text]
370. Infection: musculoskeletal.
     Pediatr Radiol, 41: S127-34. [Abstract] [Full-text]
371. Methicillin-resistant Staphylococcus aureus: the European landscape.
     J Antimicrob Chemother, 66: iv43-iv48. [Abstract] [Full-text]
372. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother, 66: iv17-iv21. [Abstract] [Full-text]
373. Resistance class 1 integron in clinical methicillin-resistant Staphylococcus aureus strains in southern China, 2001-2006.
     Clin Microbiol Infect, 17(5): 714-718. [Abstract] [Full-text]
374. What are we doing about septic arthritis? A survey of UK-based rheumatologists and orthopedic surgeons.
     Clin Rheumatol, 30(5): 707-10. [Abstract] [Full-text]
375. The dominant methicillin-resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612.
     Clin Microbiol Infect, 17(5): 785-92. [Abstract] [Full-text]
376. Infection: musculoskeletal.
     Pediatr Radiol, 41: S127-34. [Abstract] [Full-text]
377. Methicillin-resistant Staphylococcus aureus: the European landscape.
     J Antimicrob Chemother, 66: iv43-iv48. [Abstract] [Full-text]
378. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother, 66: iv17-iv21. [Abstract] [Full-text]
379. Resistance class 1 integron in clinical methicillin-resistant Staphylococcus aureus strains in southern China, 2001-2006.
     Clin Microbiol Infect, 17(5): 714-8. [Abstract] [Full-text]
380. What are we doing about septic arthritis? A survey of UK-based rheumatologists and orthopedic surgeons.
     Clin Rheumatol, 30(5): 707-10. [Abstract] [Full-text]
381. The dominant methicillin-resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612.
     Clin Microbiol Infect, 17(5): 785-92. [Abstract] [Full-text]
382. Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus.
     J Clin Microbiol. [Abstract] [Full-text]
383. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
     J Antimicrob Chemother. [Abstract] [Full-text]
384. Diagnostic and Therapeutic Evaluation of Community-acquired Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infections in the Emergency Department.
     J Emerg Med. [Abstract] [Full-text]
385. Panton-Valentine Leukocidin in the Pathogenesis of Community-associated Methicillin-resistant Staphylococcus aureus Infection.
     Pediatr Neonatol, 52(2): 59-65. [Abstract] [Full-text]
386. Clinical significance of methicillin-resistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain.
     Epidemiol Infect. [Abstract] [Full-text]
387. In Vitro Potentiation of Ampicillin, Oxacillin, Norfloxacin, Ciprofloxacin, and Vancomycin by Sanguinarine Against Methicillin-Resistant Staphylococcus aureus.
     Foodborne Pathog Dis. [Abstract] [Full-text]
388. Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
     Bioorg Med Chem, 19(9): 2918-26. [Abstract] [Full-text]
389. Methicillin-Resistant Staphylococcus aureus USA300 Clone as a Cause of Lemierre's Syndrome.
     J Clin Microbiol, 49(5): 2063-6. [Abstract] [Full-text]
390. Bullous Impetigo in Children Infected with Methicillin-Resistant Staphylococcus aureus Alone or in Combination with Methicillin-Susceptible S. aureus: Analysis of Genetic Characteristics, Including Assessment of Exfoliative Toxin Gene Carriage.
     J Clin Microbiol, 49(5): 1972-4. [Abstract] [Full-text]
391. Methicillin-Resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: Evolving Strain Distribution and Resistance Patterns.
     J Clin Microbiol, 49(5): 1975-8. [Abstract] [Full-text]
392. Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Isolates in Korea.
     J Clin Microbiol, 49(5): 1979-82. [Abstract] [Full-text]
393. Recurrent Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in an HIV-Infected Person.
     J Clin Microbiol, 49(5): 2047-53. [Abstract] [Full-text]
394. Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
     Bioorg Med Chem, 19(9): 2918-26. [Abstract] [Full-text]
395. Methicillin-resistant Staphylococcus aureus USA300 clone as a cause of Lemierre's syndrome.
     J Clin Microbiol, 49(5): 2063-6. [Abstract] [Full-text]
396. Bullous impetigo in children infected with methicillin-resistant Staphylococcus aureus alone or in combination with methicillin-susceptible S. aureus: analysis of genetic characteristics, including assessment of exfoliative toxin gene carriage.
     J Clin Microbiol, 49(5): 1972-4. [Abstract] [Full-text]
397. Methicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns.
     J Clin Microbiol, 49(5): 1975-8. [Abstract] [Full-text]
398. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Korea.
     J Clin Microbiol, 49(5): 1979-82. [Abstract] [Full-text]
399. Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person.
     J Clin Microbiol, 49(5): 2047-53. [Abstract] [Full-text]
400. A family of multicyclic indolosesquiterpenes from a bacterial endophyte.
     Org Biomol Chem. [Abstract] [Full-text]
401. Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina.
     Ann Clin Microbiol Antimicrob, 10(1): 15. [Abstract] [Full-text]
402. Digital Isothermal Quantification of Nucleic Acids via Simultaneous Chemical Initiation of Recombinase Polymerase Amplification Reactions on SlipChip.
     Anal Chem, 83(9): 3533-40. [Abstract] [Full-text]
403. Identification of Pyruvate Kinase in Methicillin-Resistant Staphylococcus aureus as a Novel Antimicrobial Drug Target.
     Antimicrob Agents Chemother, 55(5): 2042-53. [Abstract] [Full-text]
404. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
     Antimicrob Agents Chemother, 55(5): 1867-73. [Abstract] [Full-text]
405. Impact of Ciprofloxacin Exposure on Staphylococcus aureus Genomic Alterations Linked with Emergence of Rifampin Resistance.
     Antimicrob Agents Chemother, 55(5): 1946-52. [Abstract] [Full-text]
406. Emergence of Linezolid-Resistant Mutants in a Susceptible-Cell Population of Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother, 55(5): 2466-8. [Abstract] [Full-text]
407. Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother, 55(5): 2325-34. [Abstract] [Full-text]
408. Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure.
     Antimicrob Agents Chemother, 55(5): 2018-25. [Abstract] [Full-text]
409. In Vitro Activity of Fusidic Acid (CEM-102, Sodium Fusidate) against Staphylococcus aureus Isolates from Cystic Fibrosis Patients and Its Effect on the Activities of Tobramycin and Amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
     Antimicrob Agents Chemother, 55(5): 2417-9. [Abstract] [Full-text]
410. Characterization of a Novel Arginine Catabolic Mobile Element (ACME) and Staphylococcal Chromosomal Cassette mec Composite Island with Significant Homology to Staphylococcus epidermidis ACME Type II in Methicillin-Resistant Staphylococcus aureus Genotype ST22-MRSA-IV.
     Antimicrob Agents Chemother, 55(5): 1896-905. [Abstract] [Full-text]
411. Case Report of a Successful Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia and MRSA/Vancomycin-Resistant Enterococcus faecium Cholecystitis by Daptomycin.
     Antimicrob Agents Chemother, 55(5): 2458-9. [Abstract] [Full-text]
412. Impact of Dose De-Escalation and Escalation on Daptomycin's Pharmacodynamics against Clinical Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Model.
     Antimicrob Agents Chemother, 55(5): 2160-5. [Abstract] [Full-text]
413. Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria.
     Antimicrob Agents Chemother, 55(5): 1883-90. [Abstract] [Full-text]
414. Mupirocin Resistance in Staphylococcus aureus Causing Recurrent Skin and Soft Tissue Infections in Children.
     Antimicrob Agents Chemother, 55(5): 2431-3. [Abstract] [Full-text]
415. Laser disruption and killing of methicillin-resistant Staphylococcus aureus biofilms.
     Am J Otolaryngol, 32(3): 198-202. [Abstract] [Full-text]
416. Digital isothermal quantification of nucleic acids via simultaneous chemical initiation of recombinase polymerase amplification reactions on SlipChip.
     Anal Chem, 83(9): 3533-40. [Abstract] [Full-text]
417. Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
     Antimicrob Agents Chemother, 55(5): 2042-53. [Abstract] [Full-text]
418. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
     Antimicrob Agents Chemother, 55(5): 1867-73. [Abstract] [Full-text]
419. Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.
     Antimicrob Agents Chemother, 55(5): 1946-52. [Abstract] [Full-text]
420. Emergence of linezolid-resistant mutants in a susceptible-cell population of methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother, 55(5): 2466-8. [Abstract] [Full-text]
421. Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother, 55(5): 2325-34. [Abstract] [Full-text]
422. Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.
     Antimicrob Agents Chemother, 55(5): 2018-25. [Abstract] [Full-text]
423. In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
     Antimicrob Agents Chemother, 55(5): 2417-9. [Abstract] [Full-text]
424. Characterization of a novel arginine catabolic mobile element (ACME) and staphylococcal chromosomal cassette mec composite island with significant homology to Staphylococcus epidermidis ACME type II in methicillin-resistant Staphylococcus aureus genotype ST22-MRSA-IV.
     Antimicrob Agents Chemother, 55(5): 1896-905. [Abstract] [Full-text]
425. Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.
     Antimicrob Agents Chemother, 55(5): 2458-9. [Abstract] [Full-text]
426. Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model.
     Antimicrob Agents Chemother, 55(5): 2160-5. [Abstract] [Full-text]
427. Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria.
     Antimicrob Agents Chemother, 55(5): 1883-90. [Abstract] [Full-text]
428. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
     Antimicrob Agents Chemother, 55(5): 2431-3. [Abstract] [Full-text]
429. Laser disruption and killing of methicillin-resistant Staphylococcus aureus biofilms.
     Am J Otolaryngol, 32(3): 198-202. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.